![]() |
Technical Data |
|
B2553-51A |
Bone Morphogenic Protein 14, Human, Western Blot Control (BMP14, CDMP1, Cartilage-Derived Morphogenetic Protein-1, GDF-5) |
10ug 50ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
Recombinant human GDF-5 produced in E. coli is a homodimer, non-glycosylated, polypeptide chain containing two 117aa and having a total molecular mass of 26.8kD. To enable bacterial expression of rhGDF-5 we removed the N-terminal sequence Ala-Pro-Leu-Thr and added the Lysine. Endotoxin: <0.1EU/ug (LAL) Biological Activity: Human GDF-5 is fully biologically active when compared to standard. The ED50, determined by the ability to induce alkaline phosphatase activity in ATDC5 cells is 20-30ng/ml. Amino Acid Sequence: APSATRQGKR PSKNLKARCS RKALHVNFKD MGWDDWIIAP LEYEAFHCEG LCEFPLRSHL EPTNHAVIQT LMNSMDPEST PPTCCVPTRL SPISILFIDS ANNVVYKQYE DMVVESCGCR Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O, 0.1% BSA or HSA. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. CAS Number: N/A Molecular Weight: 26.8kD |
Source: Recombinant, protein corrrsponding to human Bone Morphogenic Protein 14, expressed in E. coli Purity: 98% as determined by HPLC; Reducing and non-reducing SDS-PAGE. Form: Supplied as a lyophilized powder. Reconstitute with sterile ddH2O to a concentration of 0.1mg/ml, which can be further diluted into other aqueous solutions. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||